NASDAQ:APRE

Aprea Therapeutics Stock Predictions

etoro logo Buy APRE
*Your capital is at risk
$0.762
-0.0022 (-0.288%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

APRE Prediction Chart

APRE Predictions History

Latest community submissions for APRE.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 19, 2026 $0.701 -3.74% $0.82 X 85.68% 0
Feb 19, 2026 Bearish $0.82 X 0
Feb 17, 2026 $0.652 +7.06% $0.600 X 91.26% 0
Feb 17, 2026 $0.636 +4.41% $0.600 X 93.95% 0
Feb 17, 2026 Bullish $0.600 X 0
Feb 11, 2026 $0.687 +7.38% $0.613 X 87.97% 0
Feb 11, 2026 $0.670 +4.61% $0.613 X 90.85% 0
Feb 11, 2026 Bearish $0.613 V 1
Feb 9, 2026 $0.740 +7.25% $0.660 X 87.88% 0
Feb 9, 2026 $0.721 +4.53% $0.660 X 90.72% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for APRE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT APREA THERAPEUTICS INC.
Aprea Therapeutics
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE